23 May 2013
Keywords: sprycel, gets, expedited, approval, cml, drug, major
Article | 10 July 2006
US drug major Bristol-Myers Squibb says that the Food and Drug Administration has granted accelerated approval for Sprycel (dasatinib),
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 July 2006
© 2013 thepharmaletter.com